Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular β-catenin and stimulation of β-catenin-responsive transcription

Journal of Virology

Volumn 79, Issue 8, 2005, Pages 5006-5016

  Street, Andrew ^a   Macdonald, Andrew ^a,b   McCormick, Christopher ^a   Harris, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPROTEIN; PROTEIN KINASE B; TETRACYCLINE; TRANSCRIPTION FACTOR FKHR; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS; COLON TUMOR; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR; VIRUS INFECTION; VIRUS RECOMBINANT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BACULOVIRIDAE; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; PLASMIDS; TRANS-ACTIVATORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 16244364798     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.8.5006-5016.2005     Document Type: Article

References (49)

1. Alessi, D. R., M. Deak, A. Casamayor, F. B. Caudwell, N. Morrice, D. G. Norman, P. Gaffney, C. B. Reese, C. N. MacDougall, D. Harbison, A. Ashworth, and M. Bownes. 1997. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:776-789.
2. Barker, N., P. J. Morin, and H. Clevers. 2000. The Yin-Yang of TCF/beta-catenin signaling. Adv. Cancer Res. 77:1-24.
3. Besnard-Guerin, C., N. Belaidouni, I. Lassot, E. Segeral, A. Jobart, C. Marchai, and R. Benarous. 2004. HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. J. Biol. Chem. 279:788-795.
4. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
5. Carruba, G., M. Cervello, M. D. Miceli, R. Farruggio, M. Notarbartolo, L. Virruso, L. Giannitrapani, R. Gambino, G. Montalto, and L. Castagnetta. 1999. Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Ann. N. Y. Acad. Sci. 886:212-216.
6. Cha, M. Y., C. M. Kim, Y. M. Park, and W. S. Ryu. 2004. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 39:1683-1693.
7. Chung, Y. L., M. L. Sheu, and S. H. Yen. 2003. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int. J. Cancer 107:65-73.
8. Coffer, P. J., J. Jin, and J. R. Woodgett. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1-13.
9. Coito, C., D. L. Diamond, P. Neddermann, M. J. Korth, and M. G. Katze. 2004. High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein. J. Virol. 78:3502-3513.
10. Cooray, S. 2004. The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85:1065-1076.
11. Cory, S., and J. M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2:647-656.
12. Cui, J., X. D. Zhou, Y. K. Liu, Z. Y. Tang, and M. Romeih. 2003. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. J. Gastroenterol. Hepatol. 18:280-287.
13. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
14. de La Coste, A., B. Romagnolo, P. Billuart, C. A. Renard, M. A. Buendia, O. Soubrane, M. Fabre, J. Chelly, C. Beldjord, A. Kahn, and C. Perret. 1998. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95:8847-8851.
15. Desbois-Mouthon, C., M. J. B. V. Eggelpoel, E. Beurel, M. Boissan, R. Delelo, A. Cadoret, and J. Capeau. 2002. Dysregulation of glycogen synthase kinase-3 beta signaling in hepatocellular carcinoma cells. Hepatology 36:1528-1536.
16. Doble, B. W., and J. R. Woodgett. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116:1175-1186.
17. Fujimuro, M., and S. D. Hayward. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3β. J. Virol. 77:8019-8030.
18. Fujimuro, M., F. Y. Wu, C. ApRhys, H. Kajumbula, D. B. Young, G. S. Hayward, and S. D. Hayward. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9:300-306.
19. Fukumoto, S., C. M. Hsieh, K. Maeraura, M. D. Layne, S. F. Yet, K. H. Lee, T. Matsui, A. Rosenzweig, W. G. Taylor, J. S. Rubin, M. A. Perrella, and M. E. Lee. 2001. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276:17479-17483.
20. Gan, D. D., and K. Khalili. 2004. Interaction between JCV large T-antigen and beta-catenin. Oncogene 23:483-490.
21. Ghosh, A. K., M. Majumder, R. Steele, K. Meyer, R. Ray, and R. B. Ray. 2000. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res. 67:173-178.
22. Ghosh, A. K., R. Steele, K. Meyer, R. Ray, and R. B. Ray. 1999. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J. Gen. Virol. 80:1179-1183.
23. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
24. Gotoh, J., M. Obata, M. Yoshie, S. Kasai, and K. Ogawa. 2003. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis 24:435-442.
25. Hart, M., J. P. Concordet, I. Lassot, I. Albert, R. del los Santos, H. Durand, C. Perret, B. Rubinfeld, F. Margottin, R. Benarous, and P. Polakis. 1999. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 9:207-210.
26. He, Y. P., H. H. Nakao, S. L. Tan, P. J. Polyak, P. Neddermann, S. Vijaysri, B. L. Jacobs, and M. G. Katze. 2002. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J. Virol. 76:9207-9217.
27. Huang, H., H. Fujii, A. Sankila, B. M. Mahler-Araujo, M. Matsuda, G. Cathomas, and H. Ohgaki. 1999. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 155:1795-1801.
28. Krieger, N., V. Lohmann, and R. Bartenschlager. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75:4614-4624.
29. Lan, K. H., M. L. Sheu, S. J. Hwang, S. H. Yen, S. Y. Chen, J. C. Wu, Y. J. Wang, N. Kato, M. Omata, F. Y. Chang, and S. D. Lee. 2002. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21:4801-4811.
30. Levy, L., C. Neuveut, C. A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A. F. Petit-Bertron, D. Mathieu, and M. A. Buendia. 2002. Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J. Biol. Chem. 277:42386-42393.
31. Macdonald, A., K. Crowder, A. Street, C. McCormick, and M. Harris. 2004. The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J. Gen. Virol. 85:721-729.
32. Macdonald, A., K. Crowder, A. Street, C. McCormick, K. Saksela, and M. Harris. 2003. The hepatitis C virus NS5A protein inhibits activating protein-1 function by perturbing Ras-ERK pathway signalling. J. Biol. Chem. 278:17775-17784.
33. Macdonald, A., and M. Harris. 2004. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85:2485-2502.
34. McCormick, C. J., L. Challinor, A. Macdonald, D. J. Rowlands, and M. Harris. 2004. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J. Gen. Virol. 85:429-439.
35. McCormick, C. J., D. J. Rowlands, and M. Harris. 2002. Efficient delivery and regulable expression of hepatitis C virus full length and mini-genome constructs in hepatocyte-derived cell lines using baculovirus vectors. J. Gen. Virol. 83:383-394.
36. Miyasaka, Y., N. Enomoto, M. Kurosaki, N. Sakamoto, N. Kanazawa, T. Kohashi, E. Ueda, S. Maekawa, H. Watanabe, N. Izumi, C. Sato, and M. Watanabe. 2003. Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-alpha-mediated apoptosis in Huh7 cells. J. Infect. Dis. 188:1537-1544.
37. Morin, P. J., A. B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K. W. Kinzler. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790.
38. Morrison, J. A., A. J. Klingelhutz, and N. Raab-Traub. 2003. Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J. Virol. 77:12276-12284.
39. Owsianka, A., R. F. Clayton, L. D. Loomis-Price, J. A. McKeating, and A. H. Patel. 2001. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J. Gen. Virol. 82:1877-1883.
40. Park, K. J., S. H. Choi, S. Y. Lee, S. B. Hwang, and M. M. C. Lai. 2002. Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation. J. Biol. Chem. 277:13122-13128.
41. Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851.
42. Polakis, P., M. Hart, and B. Rubinfeld. 1999. Defects in the regulation of beta-catenin in colorectal cancer. Adv. Exp. Med. Biol. 470:23-32.
43. Sarcar, B., A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray. 2004. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 322:51-60.
44. Shih, I. M., J. Yu, T. C. He, B. Vogelstein, and K. W. Kinzler. 2000. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res. 60:1671-1676.
45. Street, A., A. Macdonald, K. Crowder, and M. Harris. 2004. The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase dependent survival signalling cascade. J. Biol. Chem. 279:12232-12241.
46. Waris, G., A. Livolsi, V. Imbert, J. F. Peyron, and A. Siddiqui. 2003. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J. Biol. Chem. 278:40778-40787.
47. Willems, M., H. J. Metselaar, H. W. Tilanus, S. W. Schalm, and R. A. de Man. 2002. Liver transplantation and hepatitis C. Transplant Int. 15:61-72.
48. Yanagi, M., R. H. Purcell, S. U. Emerson, and J. Bukh. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 94:8738-8743.
49. Zoulim, F., M. Chevallier, M. Maynard, and C. Trepo. 2003. Clinical consequences of hepatitis C virus infection. Rev. Med. Virol. 13:57-68.